Collegium Pharmaceutical (COLL) PT Raised to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $22.66 +0.09%
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $35.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
- Paychex (PAYX) PT Lowered to $105 at TD Cowen
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.25 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
